Idiopathic Inflammatory Myopathies
44
18
21
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.3%
1 terminated out of 44 trials
88.9%
+2.4% vs benchmark
5%
2 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (44)
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
A Study of AZD0120 in Autoimmune Diseases
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders
MTS109 in Patients With Refractory Autoimmune Diseases
Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases
Tongji NADs Cohort
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Idiopathic Inflammatory Myopathy (IIM)
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases